Kolon TissueGene has issued a formal apology to shareholders after TG-C, its cell-gene therapy for knee osteoarthritis, ...

Mesothelioma cells, like many cancer cells, produce unusually high amounts of reactive oxygen species. These unstable ...

Tuesday’s storms brought 5 to 6 inches of rainfall and damaging winds to parts of West Virginia, leading to flash flooding, landslides, road closures and other dangers throughout the state, officials ...

Occult hepatitis B virus (OBI) infection presents a significant global health challenge, notoriously flying under the radar ...

Modern imaging is increasingly expected to do more than “take a picture.” In many real-world scenarios, what matters is not only the overall brightness of an object, but also where its boundaries, ...

Kolon TissueGene misses US phase 3 efficacy, pins approval on second trial Second pivotal readout and FDA talks now pivotal ...

SKNV, a leader in dermatologic innovation and customized prescription medications, has been granted exclusive commercialization rights under a sub-license to the patent portfolio owned by Washington ...

Group sales were +6% at constant exchange rates (CER) 1, -2% when reported in CHF and +8% in USD 2, in the first six months, driven by high demand for innovative medicines and dia ...

Verismo Therapeutics, a clinical-stage multi-chain CAR T cell therapy company pioneering a novel KIR-CAR platform technology, today announced a new preclinical KIR-CAR program targeting the clinically ...

Dr. Ascheim has over 30 years of clinical and executive experience advancing breakthrough therapies, including gene, cell, ...

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation's top cancer centers by U.

City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U ...